Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Vivo Ventures (formerly Bio Asia)

1.Vivo Ventures: Our Team   (40%):
Our Team Dr. Frank Kung Managing Partner Dr. Kung is a founding member of Vivo Ventures Investments, LLC (formerly BioAsia Investments), a healthcare/biotechnology venture capital management firm in Palo Alto, California. Dr. Kung started his career in the biotechnology industry in 1979 when he join...
2.Vivo Ventures: News & Events   (36%):
News & Events Aspreva Pharmaceuticals Reports First Quarter 2005 Results and Provides Guidance Victoria, B.C., Canada; May 12, 2005 HAMILTON Pharmaceuticals, Inc., Raises $11 Million in Series A Funding; Washington DC, April 22, 2005 Prestwick Pharmaceutical Files IPO For Up To $74.75 Million In...
3.Vivo Ventures: About Us   (33%):
About Vivo Investment Strategy At Vivo Ventures, we believe in data. By leveraging our internal expertise in evaluating data, Vivo Ventures has generated a history of outsized returns for company founders and employees as well as for our investors. Indeed, Vivo prides itself on its working relations...
4.Vivo Ventures   (33%):
Vivo Ventures is a life-sciences focused venture capital firm formed in 1996 with $400 MM under management. Vivo Ventures is currently making investments from its $179 MM fifth fund, Vivo Ventures Fund V, into promising biotechnology and life science companies. With over 90 years of scientific and o...
5.Vivo Ventures   (33%):
Vivo Ventures is a life-sciences focused venture capital firm formed in 1996 with $400 MM under management. Vivo Ventures is currently making investments from its $179 MM fifth fund, Vivo Ventures Fund V, into promising biotechnology and life science companies. With over 90 years of scientific and o...
6.Vivo Ventures: News & Events   (31%):
News & Events HAMILTON Pharmaceuticals, Inc., Raises $11 Million in Series A Funding Washington DC, April 22, 2005 -- Hamilton Pharmaceuticals Inc. (Hamilton) today announced the closing of the company's Series A financing round for a total of $11 million. In this round, founding investors in th...
7.AAMA   (30%):
LOG IN JOIN US CONTACT HOME ABOUT US EVENTS NEWS sort by name alphabetical order by last name sort by event alphabetical order by event speakers BY EVENT CALENDAR EVENT HISTORY PROGRAMS SPEAKER GALLERY AAMA QUESTIONAIRE PHOTO GALLERY SPONSORSHIP JOIN US Throughout our history, AAMA has always based...
8.EQUITY - Communities   (29%):
eQUITY About EQY Table of Companies Categories The Team Contact Information SubmitVenture COMMUNITY COMPANIES Executive Summary Business Plan Financials Bios New York, NY, September 5, 2000 -- HalfthePlanet.com, the Internet's leading online resource for goods, services, information, and community ...
9.Vivo Ventures: News & Events   (29%):
News & Events Prestwick Pharmaceutical Files IPO For Up To $74.75 Million In Common Stock WASHINGTON, April 22, 2005 (Dow Jones) -- Prestwick Pharmaceuticals Inc. filed an initial public offering Friday to sell up to $74.75 million in common stock, according to a Form S-1 filed with the Securiti...
10.JAFCO Ventures   (26%):
Chuan joined JAFCO Ventures as a Partner in 2003 bringing almost ten years of experience working with emerging technology companies. Prior to JAFCO Ventures, Chuan worked for JAFCO Co., Ltd. in a variety of roles, including as a venture investor in their Global Information Technology Investment Grou...
11.European Development Finance Institutions - EDFI Website Home   (26%):
Home About us Chairman's Statement European Financing Partners (EFP) Publications Links Contact Us FAQs What is Development Finance? Global Development Finance in 2004 Glossary of Terms News EDFI/EIB co-operation New EDFI Member - Corvinus from Hungary Belgian Investment Company for Developing Count...
12.Castile Ventures | Team: Liz Neal   (24%):
Bios of Castile partners: > Nina Saberi > Marcia Hooper > Roger Walton > David Duval a nd the Castile team: > Liz Neal > Jason King > Carolyn Wells Liz H. S. Neal Liz Neal is Castile Ventures' Director of Strategic Relations, focusing on all aspects of communications between Cas...
13.Delphi Ventures   (24%):
Archived Press Releases 6/27/2000 Xenogen Hailed by Fortune Small Business ALAMEDA, Calif.–(BUSINESS WIRE)–June 27, 2000– Third Annual Survey Places Xenogen Corporation among Top 25 Young Companies with Breakthrough Products, Services and Technologies Xenogen Corporation, a leader and...
14.Vivo Ventures: Contact Us   (24%):
Contact Us Vivo Ventures 575 High Street, Suite 201 Palo Alto, CA 94301 (650) 688-0818 Map of Vivo Ventures Street Parking is available along both High and Hamilton Street Directions to Vivo Ventures From SFO Start out going East on DOMESTIC TERMINAL toward AIRPORT EXIT. (0.1 miles) Turn LEFT onto A...
15.Delphi Ventures   (24%):
Archived Press Releases 8/24/2000 Xenogen and Cubist Pharmaceuticals Enter Into Evaluation Licensing Agreement –Agreement Focuses on Xenogen's Unique in vivo Imaging Technology in Antiinfective Modeling– Alameda, CA (August 24, 2000) – Xenogen Corporation today announced it has entere...
16.Delphi Ventures   (24%):
Archived Press Releases 5/10/2000 Xenogen Grants New Evaluation License For Its Unique, Patented Real-Time In Vivo ALAMEDA, Calif., May 10 /PRNewswire/ – Xenogen Corporation, a leader and innovator in the field of real-time in vivo imaging, today announced it has entered into an evaluation lice...
17.Vivo Ventures: News & Events   (23%):
News & Events Avera Pharmaceuticals Raises $48 million in Series C Venture Financing; New Board Members Named SAN DIEGO - August 4, 2004 -- Avera Pharmaceuticals, Inc., a privately held pharmaceutical development company focused on medicines for psychiatric and neurologic illnesses, today announ...
18.Vivo Ventures: Our Portfolio   (22%):
Our Portfolio Angiogenix is a biopharmaceutical company developing products for acute and chronic treatment of ischemia. www.angiogenix.com American Pharmaceutical Partners, Inc. (APP) is a strategically integrated pharmaceutical company that manufactures, markets and develops injectable products, w...
19.JAFCO Ventures   (22%):
Tom Mawhinney joined JAFCO Ventures as a General Partner in 2003, bringing a 15-year background in the technology industry as both a venture capitalist and an entrepreneur. Tom focused his entrepreneurial activities in the enterprise software sector but brings to JAFCO Ventures a wide range of exper...
20.APV Technology Partners   (21%):
William J. Stewart, General Partner Investments Astoria Software (formerly TeraLytics/TopicalNet) BUYandHOLD (acquired by Fahnestock) Lexar Media (Public) OKENA (acquired by Cisco) Packet Engines (acquired by Alcatel) SecureTax.com (acquired by Intuit) Experience Co-Founder and General Partner sinc...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others